Article
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.
Vaccine - 12 Jun 2014
Kalnin Kirill, Tibbitts Timothy, Yan Yanhua, Stegalkina Svetlana, Shen Lihua, Costa Victor, Sabharwal Robert, Anderson Stephen F, Day Patricia M, Christensen Neil, Schiller John T, Jagu Subhashini, Roden Richard B S, Almond Jeffrey, Kleanthous Harold
Abstract excerpt
Genetically modified bacterial flagellin (Fla), a Toll-like receptor-5 (TLR5) ligand, was evaluated as a fusion partner for human papillomavirus (HPV) L2-based immunogens in two animal challenge models; either cutaneous inoculation of rabbits with HPV 'quasivirions' containing cottontail rabbit papillomavirus (CRPV) genomes that induce warts, or intra-vaginal inoculation of mice with HPV 'pseudovirions'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
